Non-invasive evaluation of the effect of metoprolol on the atrioventricular node during permanent atrial fibrillation

Europace. 2014 Nov;16 Suppl 4:iv129-iv134. doi: 10.1093/europace/euu246.

Abstract

Aims: During atrial fibrillation (AF), conventional electrophysiological techniques for assessment of refractory period or conduction velocity of the atrioventricular (AV) node cannot be used. We aimed at evaluating changes in AV nodal properties during administration of metoprolol from electrocardiogram data, and to support our findings with simulated data based on results from an electrophysiological study.

Methods and results: Sixty patients (age 71 ± 9 years, 42 men) with permanent AF were included in the RATe control in Atrial Fibrillation (RATAF) study. Two 15 min segments, during baseline and metoprolol administration, starting at 2 pm were analysed in this study. Atrial fibrillatory rate (AFR), heart rate (HR), and AV nodal parameters were assessed. The AV nodal parameters account for the probability of an impulse not taking the fast pathway, the absolute refractory periods of the slow and fast pathways (aRPs and aRPf), representing the functional refractory period, and their respective prolongation in refractory period. In addition, simulated RR series were generated that mimic metoprolol administration through prolonged AV conduction interval and AV node effective refractory period. During metoprolol administration, AFR and HR were significantly decreased and aRP was significantly prolonged in both pathways (aRPs: 337 ± 60 vs. 398 ± 79 ms, P < 0.01; aRPf: 430 ± 91 vs. 517 ± 100 ms, P < 0.01). Similar results were found for the simulated RR series, both aRPs and aRPf being prolonged with metoprolol (aRPs: 413 ± 33 vs. 437 ± 43 ms, P = 0.01; aRPf: 465 ± 40 vs. 502 ± 69 ms, P = 0.02).

Conclusion: The AV nodal parameters reflect expected changes after metoprolol administration, i.e. a prolongation in functional refractory period. The simulations confirmed that aRPs and aRPf may serve as an estimate of the functional refractory period.

Trial registration: ClinicalTrials.gov NCT00313157.

Keywords: Atrial fibrillation; Atrioventricular node; Beta-blocker; Functional refractory period; Metoprolol; Rate control; Refractory period; Ventricular rate.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Aged
  • Aged, 80 and over
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Atrioventricular Node / drug effects*
  • Atrioventricular Node / physiopathology
  • Computer Simulation
  • Cross-Over Studies
  • Electrophysiologic Techniques, Cardiac
  • Female
  • Heart Rate / drug effects*
  • Humans
  • Male
  • Metoprolol / therapeutic use*
  • Middle Aged
  • Models, Cardiovascular
  • Predictive Value of Tests
  • Prospective Studies
  • Refractory Period, Electrophysiological
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents
  • Metoprolol

Associated data

  • ClinicalTrials.gov/NCT00313157